|
⚲
|
| Baker Bros Advisors LP
✚
|
|
|---|---|
| CRD # | 158149 |
| SEC # | 801-73446 |
| CIK # | 0001263508 |
| AUM | $23.6 BB (100% Disc, 100% US, 2020-03-25) |
| Employees | 40 (40% Investors, 0% Brokers) |
| Phone | 212-339-5600 |
| Address | 860 Washington Street, 3rd Floor New York, NY 10014 |
| Source | [IAPD] [EDGAR] |
| Total AUM ($BB) |
|---|
| Sector | Form 13F Holdings | Cap ($BB) | Value ($BB) |
|---|---|---|---|
| BGNE | 7.6 | 3.8 | |
| INCY | 14.5 | 2.9 | |
| KOD | 0.3 | 0.7 | |
| BMRN | 15.0 | 0.6 | |
| NCNA | 0.5 | 0.5 | |
| NVTA | 0.8 | 0.5 | |
| MYOK | 1.6 | 0.4 | |
| ARGX | 3.6 | 0.3 | |
| MRTX | 1.4 | 0.2 | |
| IGMS | 0.2 | ||
| View All | |||
| Holdings by Sector ($BB) |
|---|
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| HF | 14159 LP | 2012-02-13 | 17.0 | |
| HF | 667 LP | 2012-02-13 | 1,898.8 | |
| HF | Baker Biotech Fund II A LP | 2012-02-13 | 9.4 | |
| HF | Baker Bros Investments II LP | 2012-02-13 | 1.2 | |
| HF | Baker Bros Investments LP | 2012-02-13 | 9.8 | |
| HF | Baker Brothers Life Sciences LP | [2012-02-13] | 0.0 | 21,642.2 |
| HF | Baker/Tisch Investments LP | 2012-02-13 | 11.0 |
| Form D Directors | # Filings | # Firms | 2011 - 2021 |
|---|---|---|---|
| General Partner Baker Brothers Life Sciences Capital LP | 8 |
| EDGAR Form | CIK | 2011 - 2021 |
|---|---|---|
| 13F-HR | [0001263508] | |
| 3 | [0001263508] | |
| 4 | [0001263508] | |
| SC 13D | [0001263508] | |
| SC 13G | [0001263508] |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
Knights of Columbus Asset Advisors LLC
✚
|
CT | 26.3 |
|
GSO Capital Advisors LLC
✚
|
NY | 25.7 |
|
Nomura Corporate Research and Asset Management Inc
✚
|
NY |